cancer research Wales

Dr. Mark Bouzyk to Keynote at the 50th anniversary of Cancer Research Wales, Ymchwil Canser Cymru

March 1st, 2016 – Dr. Mark Bouzyk, CSO of AKESOgen, has been invited to the SWALEC stadium in Cardiff, U.K for the Cancer Research Wales 50th anniversary.   March 1st commemorates St. David’s day, a national day of celebration within Wales. Cancer Research Wales will be showcasing its milestones and research achievements over the last 50 years with the theme of the symposium is “Cancer Research Wales at 50 Working Towards Precision Medicine.”  The symposium will bring together top cancer scientists and clinicians from across Wales and the UK giving them an opportunity to discuss and share their latest findings but also plan future collaborations.

 

Cancer Research WalesAKESOgen-Logo333

Share this Facebooktwittergoogle_plusredditlinkedinmailFacebooktwittergoogle_plusredditlinkedinmail
CAP

AKESOgen Receives Accreditation from College of American Pathologists

CAP 2

Atlanta, GA – 8th February 2016 – Personalized Medicine and genomics company AKESOgen, announced today Accreditation from the College of American Pathologists (CAP).

The AKESOgen facility in Atlanta completed a comprehensive on-site inspection and analysis of its oncology testing as part of the CAP’s Accreditation Programs. The CAP Laboratory Accreditation Program involves a process of inspections of clinical lab records and quality control procedures and assessments of a lab’s staff qualifications, equipment, facilities, safety program, and overall management.

“This is an important endorsement by the College of American Pathologists for AKESOgen to provide our comprehensive cytogenomics oncology tests and services for a wide spectrum of solid and liquid tumors and will be of particular benefit to patients –as the tests are offered as a complement to NGS clinical oncology testing,” commented Gabriela M. Oprea, MD, the facility’s director.

“AKESOgen is honored to achieve accreditation from the College of American Pathologists. CAP accreditation is viewed as the ‘crème de la crème’ for laboratory testing. The whole team at AKESOgen is proud to be awarded this prestigious accreditation. This achievement strengthens our commitment to enabling Precision Medicine at the highest quality possible,” said Dr Mark Bouzyk, CSO of AKESOgen.

 About AKESOgen, Inc.

AKESOgen is an integrated genomics, genetics and bio-banking company that services the pharmaceutical, biotechnology, clinical, academic, and government sectors for clinical trials, diagnostic clinical testing, and research. Based in Atlanta, GA, USA, the company’s main focus is oncology and personalized medicine. AKESOgen’s services include providing high-throughput biomarker profiling, cytogenetic arrays, sequencing, and genomics analyses utilizing different types of markers (e.g. DNA, mRNA, miRNA, and methylation). For more information, visit www.akesogen.com.

About the College of American Pathologists

As the leading organization with more than 18,000 board-certified pathologists, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. The CAP’s Laboratory Improvement Programs, initiated 65 years ago, currently have customers in more than 100 countries, accrediting 7,700 laboratories and providing proficiency testing to 20,000 laboratories worldwide. Find more information about the CAP at www.cap.org. Follow CAP on Twitter: @pathologists.

Media Contact:

Marissa Cooke, Client Relations Specialist, Scientific Affairs, AKESOgen, Inc. +1 770-542-0890 or mcooke@akesogen.com

CAP-logo-750x456

Share this Facebooktwittergoogle_plusredditlinkedinmailFacebooktwittergoogle_plusredditlinkedinmail